A number of research firms have changed their ratings and price targets for Gerresheimer (ETR: GXI):

  • 2/6/2018 – Gerresheimer was given a new €55.00 ($67.90) price target on by analysts at Hauck & Aufhaeuser. They now have a “sell” rating on the stock.
  • 2/6/2018 – Gerresheimer was given a new €65.00 ($80.25) price target on by analysts at Kepler Capital Markets. They now have a “sell” rating on the stock.
  • 2/6/2018 – Gerresheimer was given a new €87.70 ($108.27) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 2/5/2018 – Gerresheimer was given a new €77.00 ($95.06) price target on by analysts at Commerzbank Ag. They now have a “buy” rating on the stock.
  • 1/25/2018 – Gerresheimer was given a new €74.00 ($91.36) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 1/25/2018 – Gerresheimer was given a new €68.00 ($83.95) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 1/24/2018 – Gerresheimer was given a new €55.00 ($67.90) price target on by analysts at Hauck & Aufhaeuser. They now have a “sell” rating on the stock.
  • 1/22/2018 – Gerresheimer was given a new €66.00 ($81.48) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 1/19/2018 – Gerresheimer was given a new €75.00 ($92.59) price target on by analysts at equinet AG. They now have a “neutral” rating on the stock.
  • 1/18/2018 – Gerresheimer was given a new €55.00 ($67.90) price target on by analysts at Hauck & Aufhaeuser. They now have a “sell” rating on the stock.
  • 1/10/2018 – Gerresheimer was given a new €55.00 ($67.90) price target on by analysts at Hauck & Aufhaeuser. They now have a “sell” rating on the stock.
  • 1/4/2018 – Gerresheimer was given a new €87.70 ($108.27) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.
  • 12/29/2017 – Gerresheimer was given a new €87.70 ($108.27) price target on by analysts at JPMorgan Chase & Co.. They now have a “buy” rating on the stock.

Gerresheimer AG (GXI) traded down €0.70 ($0.86) during trading hours on Thursday, hitting €65.75 ($81.17). 116,049 shares of the stock were exchanged, compared to its average volume of 110,916. Gerresheimer AG has a 12 month low of €59.97 ($74.04) and a 12 month high of €78.25 ($96.60). The company has a market capitalization of $2,090.00 and a price-to-earnings ratio of 46.63.

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Receive News & Ratings for Gerresheimer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer AG and related companies with MarketBeat.com's FREE daily email newsletter.